respiratory
Medicines

Senate overlooked price of cancer drug: experts


Experts have criticised a Senate report on access to innovative  cancer drugs for failing to take into account the impact of drug prices. Published late last year the report titled Availability of new, innovative and specialist cancer drugs in Australia addressed the health burden of cancer on society; the impact on patients of delayed access ...

Already a member?

Enter your email to keep reading.


OR